Injection site reactions after subcutaneous oligonucleotide therapy.
van Meer L, Moerland M, Gallagher J, van Doorn MB, Prens EP, Cohen AF, Rissmann R, Burggraaf J.
van Meer L, et al. Among authors: moerland m.
Br J Clin Pharmacol. 2016 Aug;82(2):340-51. doi: 10.1111/bcp.12961. Epub 2016 May 31.
Br J Clin Pharmacol. 2016.
PMID: 27061947
Free PMC article.
Review.